154 related articles for article (PubMed ID: 21965271)
21. Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine model.
Jones JA; Ruddy JM; Bouges S; Zavadzkas JA; Brinsa TA; Stroud RE; Mukherjee R; Spinale FG; Ikonomidis JS
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H114-24. PubMed ID: 20418476
[TBL] [Abstract][Full Text] [Related]
22. Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes.
Dangi-Garimella S; Redig AJ; Shields MA; Siddiqui MA; Munshi HG
J Biol Chem; 2010 Sep; 285(36):28363-72. PubMed ID: 20605790
[TBL] [Abstract][Full Text] [Related]
23. The Precise Diagnosis of Cancer Invasion/Metastasis via 2D Laser Ablation Mass Mapping of Metalloproteinase in Primary Cancer Tissue.
Zhang X; Liu R; Yuan Q; Gao F; Li J; Zhang Y; Zhao Y; Chai Z; Gao L; Gao X
ACS Nano; 2018 Nov; 12(11):11139-11151. PubMed ID: 30359513
[TBL] [Abstract][Full Text] [Related]
24. Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells.
Soulié P; Carrozzino F; Pepper MS; Strongin AY; Poupon MF; Montesano R
Oncogene; 2005 Mar; 24(10):1689-97. PubMed ID: 15608664
[TBL] [Abstract][Full Text] [Related]
25. Identification of cis-acting promoter elements that support expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) in v-src transformed Madin-Darby canine kidney cells.
Cha HJ; Okada A; Kim KW; Sato H; Seiki M
Clin Exp Metastasis; 2000; 18(8):675-81. PubMed ID: 11827071
[TBL] [Abstract][Full Text] [Related]
26. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
Roy S; Chakraborti T; Chowdhury A; Chakraborti S
J Biochem; 2013 Mar; 153(3):289-302. PubMed ID: 23266860
[TBL] [Abstract][Full Text] [Related]
27. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis.
Lemieux E; Bergeron S; Durand V; Asselin C; Saucier C; Rivard N
Int J Cancer; 2009 Oct; 125(7):1575-86. PubMed ID: 19462441
[TBL] [Abstract][Full Text] [Related]
28. YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis.
Lovett DH; Cheng S; Cape L; Pollock AS; Mertens PR
Biochem Biophys Res Commun; 2010 Jul; 398(3):482-8. PubMed ID: 20599698
[TBL] [Abstract][Full Text] [Related]
29. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
30. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration.
Williams KC; Coppolino MG
J Biol Chem; 2011 Dec; 286(50):43405-16. PubMed ID: 22002060
[TBL] [Abstract][Full Text] [Related]
32. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
33. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.
Nyalendo C; Sartelet H; Barrette S; Ohta S; Gingras D; Béliveau R
BMC Cancer; 2009 Dec; 9():422. PubMed ID: 19961596
[TBL] [Abstract][Full Text] [Related]
34. MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3.
Saeb-Parsy K; Veerakumarasivam A; Wallard MJ; Thorne N; Kawano Y; Murphy G; Neal DE; Mills IG; Kelly JD
Br J Cancer; 2008 Aug; 99(4):663-9. PubMed ID: 18665176
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.
Zhang Z; Song T; Jin Y; Pan J; Zhang L; Wang L; Li P
Int J Gynecol Cancer; 2009 Aug; 19(6):998-1003. PubMed ID: 19820359
[TBL] [Abstract][Full Text] [Related]
36.
Somsuan K; Peerapen P; Boonmark W; Plumworasawat S; Samol R; Sakulsak N; Thongboonkerd V
FASEB J; 2019 Nov; 33(11):12226-12239. PubMed ID: 31424966
[TBL] [Abstract][Full Text] [Related]
37. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
Petrella BL; Lohi J; Brinckerhoff CE
Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
[TBL] [Abstract][Full Text] [Related]
38. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Amatangelo MD; Goodyear S; Varma D; Stearns ME
Carcinogenesis; 2012 Oct; 33(10):1965-75. PubMed ID: 22791812
[TBL] [Abstract][Full Text] [Related]
39. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
